NuChem completes MBO

Montreal-based NuChem Therapeutics Inc, a drug discovery and development contract research organization, has completed a management buyout from Amorchem LP. No financial terms were disclosed. According to details of the transaction, NuChem's senior management acquired 95 percent of the voting shares from Amorchem, a Montreal-based early-stage venture firm that founded NuChem in 2011.

DealsNorth AmericaUSHealthcareBriefs